Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Stem Cell Reports ; 8(4): 1005-1017, 2017 04 11.
Artigo em Inglês | MEDLINE | ID: mdl-28285878

RESUMO

Malignant mesothelioma (MM) is an aggressive neoplasm characterized by a poor patient survival rate, because of rapid tumor recurrence following first-line therapy. Cancer stem cells (CSCs) are assumed to be responsible for initiating tumorigenesis and driving relapse after therapeutic interventions. CSC-enriched MM cell subpopulations were identified by an OCT4/SOX2 reporter approach and were characterized by (1) increased resistance to cisplatin, (2) increased sensitivity toward the FAK inhibitor VS-6063 in vitro, and (3) a higher tumor-initiating capacity in vivo in orthotopic xenograft and allograft mouse models. Overexpression of NF2 (neurofibromatosis 2, merlin), a tumor suppressor often mutated or lost in MM, did not affect proliferation and viability of CSC-enriched MM populations but robustly decreased the viability of reporter-negative cells. In contrast, downregulation of calretinin strongly decreased proliferation and viability of both populations. In summary, we have enriched and characterized a small MM cell subpopulation that bears the expected CSC characteristics.


Assuntos
Neoplasias Pulmonares/patologia , Pulmão/patologia , Mesotelioma/patologia , Células-Tronco Neoplásicas/patologia , Fator de Células-Tronco/análise , Animais , Antineoplásicos/farmacologia , Calbindina 2/análise , Proliferação de Células , Cisplatino/farmacologia , Resistencia a Medicamentos Antineoplásicos , Humanos , Pulmão/efeitos dos fármacos , Neoplasias Pulmonares/tratamento farmacológico , Mesotelioma/tratamento farmacológico , Mesotelioma Maligno , Camundongos , Células-Tronco Neoplásicas/efeitos dos fármacos , Neurofibromina 2/análise , Fator 3 de Transcrição de Octâmero/análise , Fatores de Transcrição SOXB1/análise
2.
PLoS One ; 9(3): e90853, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-24595234

RESUMO

The proper control of tissue growth is essential during normal development and an important problem in human disease. Merlin, the product of the Neurofibromatosis 2 tumor suppressor gene, has been extensively studied to understand its functions in growth control. Here we describe experiments in which we used Drosophila as an in vivo system to test the functions of the normal human NF2 gene products and patient-derived mutant alleles. Although the predominant NF2 gene isoform, isoform 1, could functionally replace the Drosophila Merlin gene, a second isoform with a distinct C-terminal tail could not. Immunofluorescence studies show that the two isoforms have distinct subcellular localizations when expressed in the polarized imaginal epithelium, and function in genetic rescue assays correlates with apical localization of the NF2 protein. Interestingly, we found that a patient-derived missense allele, NF2L64P, appears to be temperature sensitive. These studies highlight the utility of Drosophila for in vivo functional analysis of highly conserved human disease genes.


Assuntos
Drosophila/genética , Genes da Neurofibromatose 2 , Neurofibromina 2/genética , Alelos , Animais , Humanos , Mutação , Neurofibromina 2/análise , Isoformas de Proteínas/análise , Isoformas de Proteínas/genética
3.
PLoS One ; 7(11): e48897, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-23145014

RESUMO

BACKGROUND: Interstitial cells of Cajal (ICC) have been identified in urinary bladder of several species, but their presence in mice remains uncertain. Meanwhile, dozens of reports indicate that dysregulation of connexin 43 plays an important role in bladder overactivity, but its localization has not been clearly defined, with reports of expression in either the smooth muscle or in myofibroblasts. We recently identified a population of ectonucleoside triphosphate diphosphohydrolase 2 (NTPDase2) positive cells that resemble ICC and are distinct from smooth muscle, fibroblasts, myofibroblasts and neurons. Thus we sought to define more clearly the molecular signature of ICC and in doing so resolve some of these uncertainties. PRINCIPLE FINDINGS: Immunofluorescent localization revealed that NTPDase2-positive cells lie closely adjacent to smooth muscle but are separate from them. NTPDase2 positive cells exhibited co-localization with the widely accepted ICC marker - c-kit. They were further shown to co-localize with other ICC markers CD34 and Ano1, but not with mast cell marker tryptase. Significantly, they show convincing co-localization with connexin 43, which was not present in smooth muscle. The identity of these cells as ICC was further confirmed by the presence of three mesenchymal markers - vimentin, desmin, and PDGFß receptor, which indicates their mesenchymal origin. Finally, we observed for the first time, the presence of merlin/neurofibromin 2 in ICC. Normally considered a neuronal protein, the presence of merlin suggests ICC in bladder may have a role in neurotransmission. CONCLUSIONS: NTPDase2 positive cells in mice bladder are ICC, which can be defined by the presence of c-Kit, CD34, Ano1, NTPDase2, connexin 43, vimentin, desmin, PDGFß receptor and merlin/NF2. These data establish a definitive molecular expression profile, which can be used to assist in explorations of their functional roles, and the presence of NTPDase2 suggests that purinergic signaling plays a role in regulation of ICC function.


Assuntos
Células Intersticiais de Cajal/metabolismo , Células Musculares/citologia , Miofibroblastos/citologia , Bexiga Urinária/citologia , Adenosina Trifosfatases/análise , Adenosina Trifosfatases/metabolismo , Animais , Anoctamina-1 , Antígenos CD34/análise , Antígenos CD34/metabolismo , Biomarcadores/metabolismo , Canais de Cloreto/análise , Canais de Cloreto/metabolismo , Conexina 43/análise , Conexina 43/metabolismo , Desmina/análise , Desmina/metabolismo , Células Intersticiais de Cajal/citologia , Mesoderma/citologia , Mesoderma/metabolismo , Camundongos , Camundongos Endogâmicos C57BL , Células Musculares/metabolismo , Miofibroblastos/metabolismo , Neurofibromina 2/análise , Neurofibromina 2/metabolismo , Neurônios/citologia , Neurônios/metabolismo , Receptor beta de Fator de Crescimento Derivado de Plaquetas/análise , Receptor beta de Fator de Crescimento Derivado de Plaquetas/metabolismo , Triptases/análise , Triptases/metabolismo , Bexiga Urinária/metabolismo , Vimentina/análise , Vimentina/metabolismo
4.
Histochem Cell Biol ; 137(1): 1-10, 2012 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-22086768

RESUMO

Colocalization of differently labeled biomolecules is a valuable tool in fluorescence microscopy and can provide information on biomolecular interactions. With the advent of super-resolution microscopy, colocalization analysis is getting closer to molecular resolution, bridging the gap to other technologies such as fluorescence resonance energy transfer. Among these novel microscopic techniques, single-molecule localization-based super-resolution methods offer the advantage of providing single-molecule coordinates that, rather than intensity information, can be used for colocalization analysis. This requires adapting the existing mathematical algorithms for localization microscopy data. Here, we introduce an algorithm for coordinate-based colocalization analysis which is suited for single-molecule super-resolution data. In addition, we present an experimental configuration for simultaneous dual-color imaging together with a robust approach to correct for optical aberrations with an accuracy of a few nanometers. We demonstrate the potential of our approach for cellular structures and for two proteins binding actin filaments.


Assuntos
Proteínas do Citoesqueleto/análise , Microscopia de Fluorescência/métodos , Neurofibromina 2/análise , Algoritmos , Células HeLa , Humanos , Lasers
5.
Mol Cell Biochem ; 324(1-2): 201-6, 2009 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-19142715

RESUMO

The events leading to Schwannomas development are still largely unknown. Some studies have demonstrated that merlin acts as a tumor suppressor by blocking Ras-mediated signaling. In this study, we analyze the clinical and biological behaviors of seven randomly selected sporadic vestibular Schwannomas removed from the patients. We find that merlin was commonly lost in these Schwannomas, due to loss of merlin expression or phosphorylation status of merlin expression. Heightened CDKs/cyclins signal transduction concomitant with loss of p27 was well correlated with loss of functional merlin in Schwannomas. More, we show that phosphorylated merlin Schwannomas exhibited increased Ras/Rac/PAK signal transduction. That was in agreement with the severe clinical behaviors, i.e., phosphorylation status of merlin increased tumor size in sporadic vestibular Schwannomas. These results led us to suggest that phosphorylated merlin, a kind of type of mutation merlin, is involved in tumorigenesis of sporadic vestibular Schwannomas.


Assuntos
Neurofibromina 2/metabolismo , Neuroma Acústico/química , Adulto , Inibidor de Quinase Dependente de Ciclina p27/deficiência , Quinases Ciclina-Dependentes/metabolismo , Ciclinas/metabolismo , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Neurofibromina 2/análise , Neuroma Acústico/etiologia , Neuroma Acústico/patologia , Fosforilação , Transdução de Sinais , Carga Tumoral , Adulto Jovem , Proteínas ras/metabolismo
6.
Tumori ; 94(4): 551-5, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-18822692

RESUMO

Gastrointestinal stromal tumors are the most common mesenchymal tumors of the gastrointestinal tract. Until today, there have been few markers specific for the tumor. This has complicated the differential diagnosis of the neoplasm from tumors of smooth muscle origin. Recently, the proto-oncogene c-kit has been shown to be a very relevant marker as it almost invariably is expressed in gastrointestinal stromal tumors. Radiation exposure, hormonal and genetic factors, particularly neurofibromatosis 2, have been implicated in their development and growth. GIST initiation, either in NF2-associated or in sporadic cases, is linked to inactivation of members of the proteins 4.1 superfamily. The majority of the mutations identified in the NF2 gene result in a truncated protein and are clinically associated with a severe phenotype. Occasionally, missense mutations associated with a mild phenotype may occur. We compared NF2 gene expression in 5 cases with gastrointestinal stromal tumors by quantitative real-time polymerase chain reaction analysis. NF2 gene mRNA expression was assessed in fresh tissue of stomach from 5 consecutive patients. We detected no alterations in NF2 gene expression in the quantitative analyses of the 5 tumors.


Assuntos
Biomarcadores Tumorais/análise , Tumores do Estroma Gastrointestinal/química , Neurofibromina 2/análise , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Biomarcadores Tumorais/genética , Tumores do Estroma Gastrointestinal/patologia , Regulação Neoplásica da Expressão Gênica , Humanos , Mutação , Neurofibromina 2/genética , Fenótipo , Proto-Oncogene Mas , RNA Mensageiro/análise , Reação em Cadeia da Polimerase Via Transcriptase Reversa/métodos
7.
Appl Immunohistochem Mol Morphol ; 15(3): 353-7, 2007 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-17721284

RESUMO

One of the most common chromosomal regions implicated in the meningiomas tumorigenesis is 22q12 where the neurofibromatosis 2 (NF2) gene resides. The NF2 tumor-suppressor gene encodes for the merlin/schwannomin protein, which is responsible for the inherited disease neurofibromatosis 2. NF2 gene mutations predominantly occur in transitional and fibroblastic meningiomas, whereas the meningothelial variant is less affected. Secretory meningioma is an infrequent meningioma subtype. Its most typical morphologic feature is the presence of intracytoplasmic or extracytoplasmic round hyaline, eosinophilic, and periodic acid Shiff-positive bodies in a lesion frequently otherwise classifiable as meningothelial meningioma. This study reviews the immunohistochemical merlin expression in 14 consecutive secretory meningiomas. Our purpose was to investigate if secretory meningiomas, analogous to meningothelial meningiomas, follow a molecular route of pathogenesis independent of the neurorofibromatosis 2 gene-associated pathway. All meningiomas showed positive immunocoloration involving the majority of the hyaline inclusions and secretory cells; in 12 (86%) meningiomas, a positive immunoreaction was also documented in nonsecretory tumoral cells. Our results may indicate a molecular, besides morphologic, similarity between secretory and meningothelial meningiomas: the almost constant merlin immunohistochemical expression in our series gives evidence for a possible NF2 gene-independent pathogenesis in secretory meningiomas.


Assuntos
Neoplasias Meníngeas/etiologia , Meningioma/etiologia , Neurofibromina 2/metabolismo , Adulto , Idoso , Idoso de 80 Anos ou mais , Feminino , Humanos , Imuno-Histoquímica , Masculino , Neoplasias Meníngeas/genética , Neoplasias Meníngeas/patologia , Meningioma/genética , Meningioma/patologia , Pessoa de Meia-Idade , Neurofibromina 2/análise , Neurofibromina 2/genética
8.
Otol Neurotol ; 27(2): 213-9, 2006 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-16436992

RESUMO

HYPOTHESIS: Genetic and immunohistochemical studies may provide insight into the mechanisms of vestibular schwannoma (VS) recurrence following radiation therapy. BACKGROUND: Stereotactic radiation therapy is an increasingly common alternative to microsurgical resection for the primary management of sporadic VS. The molecular mechanisms associated with recurrent vestibular schwannoma (VS) following radiation therapy are not known. METHODS: Primary or irradiated VS tumors were fresh-frozen at the time of surgical resection and microdissected to undergo DNA extraction. Lymphocytic control DNA was isolated from blood obtained by venipuncture. Paired normal and tumor DNA specimens were analyzed for allelic loss by PCR amplification of polymorphic dinucleotide repeat sequences. Immunohistochemical studies were performed on paraffin-embedded, irradiated surgical specimens. RESULTS: Using 16 polymorphic microsatellite markers, 20 of 26 non-irradiated VS demonstrated loss of heterozygosity (LOH) in at least one locus of chromosome 22q. In contrast, none of the four irradiated recurrent VS demonstrated LOH on chromosome 22q (p = 0.008). No allelic loss was seen in either the primary or irradiated VS utilizing markers mapping to chromosome 10. Deletions on chromosome 10 are seen in both benign and higher-grade meningiomas and intracranial malignancies associated with radiotherapy. Immunohistochemical studies were performed to detect the protein product of the NF2 gene, merlin, in the four irradiated VS. NF2 staining was not observed. CONCLUSION: This study represents the first microsatellite and immunohistochemical analysis of recurrent VS following radiation therapy. Our preliminary observations suggest an alternative mechanism of NF2 inactivation that may correlate with radioresistance in VS.


Assuntos
Cromossomos Humanos Par 22 , Repetições de Microssatélites , Recidiva Local de Neoplasia/genética , Neuroma Acústico/genética , Neuroma Acústico/cirurgia , Radiocirurgia , Sequência de Bases , Distribuição de Qui-Quadrado , Cromossomos Humanos Par 10 , Análise Mutacional de DNA , DNA de Neoplasias/sangue , DNA de Neoplasias/química , DNA de Neoplasias/genética , DNA de Neoplasias/isolamento & purificação , Regulação Neoplásica da Expressão Gênica , Genes bcl-2/genética , Genes p53/genética , Humanos , Imuno-Histoquímica , Perda de Heterozigosidade , Neurofibromina 2/análise , Neurofibromina 2/genética , Neuroma Acústico/metabolismo
9.
Mod Pathol ; 18(7): 991-7, 2005 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-15731777

RESUMO

Ependymomas are common pediatric and adult CNS malignancies with a wide biologic spectrum that is often hard to predict using classic prognostic variables. The molecular pathogenesis is also poorly understood and few reproducible genetic alterations have been identified. The most common genetic alteration has been the loss of the Protein 4.1 family member, NF2, predominantly in spinal ependymomas. In contrast, a pilot study suggested that 4.1B deletions might be more common in intracranial ependymomas. These findings prompted us to study Protein 4.1 family members (NF2, 4.1B, 4.1R, 4.1G) in a larger cohort of 84 ependymomas (51 intracranial and 33 spinal; 11 WHO grade I, 43 grade II, 30 grade III). Fluorescence in situ hybridization was performed using NF2, 4.1B, 4.1R and 4.1G probes and immunohistochemical staining was performed in a subset using merlin, Protein 4.1B and Protein 4.1R antibodies. Additionally, frozen tissue from nine ependymomas (four intracranial and five spinal) was obtained for Western blot analysis for merlin, 4.1B and 4.1R expression. The majority of cases harbored one or more detectable genetic alterations, but we found that 4.1B gene deletions and 4.1R loss of expression were statistically more common in the pediatric vs adult, intracranial vs spinal, and grade III vs grade I/II subsets (P-values of 0.038 to <0.001). Also, 4.1G deletions were seen in 11/27 (41%) patients who either died of disease or had residual/recurrent tumor vs 5/41 patients with no evidence of disease at last follow-up (P=0.009). We conclude that alterations of Protein 4.1 family members are common in ependymal tumors and that specific alterations are associated with distinct clinicopathologic subsets.


Assuntos
Ependimoma/patologia , Proteínas de Membrana/genética , Adolescente , Adulto , Idoso , Proteínas Sanguíneas/análise , Proteínas Sanguíneas/genética , Neoplasias Encefálicas/genética , Neoplasias Encefálicas/metabolismo , Neoplasias Encefálicas/patologia , Criança , Pré-Escolar , Estudos de Coortes , Proteínas do Citoesqueleto/análise , Proteínas do Citoesqueleto/genética , Ependimoma/genética , Ependimoma/metabolismo , Humanos , Imuno-Histoquímica , Hibridização in Situ Fluorescente , Lactente , Proteínas de Membrana/análise , Proteínas dos Microfilamentos , Proteínas Associadas aos Microtúbulos/análise , Proteínas Associadas aos Microtúbulos/genética , Pessoa de Meia-Idade , Neurofibromina 2/análise , Neurofibromina 2/genética , Neoplasias da Medula Espinal/genética , Neoplasias da Medula Espinal/metabolismo , Neoplasias da Medula Espinal/patologia , Proteínas Supressoras de Tumor/análise , Proteínas Supressoras de Tumor/genética
10.
Oncogene ; 24(7): 1150-8, 2005 Feb 10.
Artigo em Inglês | MEDLINE | ID: mdl-15580288

RESUMO

The neurofibromatosis 2 tumour suppressor merlin/schwannomin is structurally related to the ezrin-radixin-moesin family of proteins, which anchor actin cytoskeleton to specific membrane proteins and participate in cell signalling. Merlin inhibits cell growth with a yet unknown mechanism. As most tumour suppressors are linked to cell cycle control, we investigated merlin's behaviour during cell cycle. In glioma and osteosarcoma cells, endogenous merlin was targeted to the nucleus in a cell cycle-specific manner. Merlin accumulated perinuclearly at the G2/M phase, and shifted to the nucleus at early G1. During mitosis, merlin localized to mitotic spindles and at the contractile ring. Nuclear merlin was strongly reduced in confluent cells. Blocking of the CRM1/exportin nuclear export pathway led to accumulation of merlin in the nucleus. Activation of the p21-activated kinase or protein kinase A, which result in phosphorylation of merlin, did not affect its nuclear localization. Merlin regulates the activity of extracellular signal-regulated kinase 2 (ERK2) and nuclear localization of both proteins was induced by cell adhesion. Unlike ERK2, nuclear localization of merlin was not, however, dependent on intact actin cytoskeleton. These results link merlin to events related to cell cycle control and may help to resolve its tumour suppressor function.


Assuntos
Ciclo Celular , Núcleo Celular/metabolismo , Glioma/metabolismo , Neurofibromina 2/metabolismo , Transporte Ativo do Núcleo Celular/fisiologia , Adesão Celular/fisiologia , Linhagem Celular Tumoral , Núcleo Celular/química , Proteínas Quinases Dependentes de AMP Cíclico/antagonistas & inibidores , Proteínas Quinases Dependentes de AMP Cíclico/fisiologia , Citoplasma/química , Citoplasma/metabolismo , Citoesqueleto/metabolismo , Glioma/química , Humanos , Carioferinas/fisiologia , Proteína Quinase 1 Ativada por Mitógeno/análise , Proteína Quinase 1 Ativada por Mitógeno/antagonistas & inibidores , Proteína Quinase 1 Ativada por Mitógeno/fisiologia , Neurofibromina 2/análise , Osteossarcoma/química , Osteossarcoma/metabolismo , Fosforilação , Proteínas Serina-Treonina Quinases/antagonistas & inibidores , Proteínas Serina-Treonina Quinases/fisiologia , Receptores Citoplasmáticos e Nucleares/fisiologia , Quinases Ativadas por p21 , Proteína Exportina 1
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...